Cited by

• Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.

  Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Aihara Y, Yamao J, Toyohara M, Mitoro A, Sawai M, Yoshida M, Morioka C, Fujimoto M, Uemura M, Kawaratani H, Tsujimoto T, Fukui H. Yoshiji H, et al. Oncol Lett. 2011 Jan;2(1):69-73. doi: 10.3892/ol.2010.196. Epub 2010 Oct 5. Oncol Lett. 2011. PMID: 22870131 Free PMC article.
• Intraoperative ablation for small HCC not amenable for percutaneous radiofrequency ablation in Child A cirrhotic patients.

  El-Gendi A, El-Shafei M, Abdel-Aziz F, Bedewy E. El-Gendi A, et al. J Gastrointest Surg. 2013 Apr;17(4):712-8. doi: 10.1007/s11605-012-2085-1. Epub 2012 Nov 21. J Gastrointest Surg. 2013. PMID: 23179908
• Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.

  Katamura Y, Aikata H, Takaki S, Azakami T, Kawaoka T, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Kenjo M, Toyota N, Ito K, Chayama K. Katamura Y, et al. J Gastroenterol. 2009;44(5):492-502. doi: 10.1007/s00535-009-0033-y. Epub 2009 Mar 28. J Gastroenterol. 2009. PMID: 19330281 Clinical Trial.
• CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

  Tsai HT, Yang SF, Chen DR, Chan SE. Tsai HT, et al. Med Oncol. 2012 Dec;29(4):2771-9. doi: 10.1007/s12032-012-0189-9. Epub 2012 Feb 29. Med Oncol. 2012. PMID: 22374185
• The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.

  Yamaoka K, Kodama K, Kawaoka T, Kosaka M, Johira Y, Shirane Y, Miura R, Yano S, Murakami S, Amioka K, Naruto K, Ando Y, Kosaka Y, Uchikawa S, Uchida T, Fujino H, Nakahara T, Murakami E, Okamoto W, Yamauchi M, Miki D, Imamura M, Takahashi S, Nagao A, Chayama K, Aikata H. Yamaoka K, et al. PLoS One. 2022 Jan 18;17(1):e0262675. doi: 10.1371/journal.pone.0262675. eCollection 2022. PLoS One. 2022. PMID: 35041693 Free PMC article.